AIM: To investigate the prevalence and genotype distribution of Torque teno virus (TTV) in patients with different liver diseases and chronic renal failure treated at a referral hospital in North India. METHODS: Whereas prevalence of TTV was based on amplification of conserved region of ORF2 of TTV genome, the genotyping of TTV was carried out using restriction fragment length polymorphism (RFLP) procedure on the N22 region of ORF1. RESULTS: TTV-DNA was detected in 137 of 513 (26.7%) patients with liver diseases and 38 of 65 (58.5%) patients with chronic renal failure. TTV was also detected in 27% of healthy controls. The sequence analysis of the PCR product from 10 randomly selected cases failed to show a significant sequence divergence when compared with that of the TRM1 isolate of TTV genotype 1. The results of genotyping in 55 randomly selected patients showed the presence of genotype 1 (G1) in 53 (96.4%) and genotype 2 (G2) in 2 cases (3.6%), respectively. Other genotypes were not identified in this patient subgroup, suggesting that G1 is predominant in this area. The results of genotyping by RFLP were also supported by phylogenetic tree analysis, where G1 was found to be the major genotype. CONCLUSION: These results indicate that TTV is moderately present in Indian patients, with G1 to be the major genotype in North India. The pathogenicity and etiological role of TTV in different diseases is still a question mark and warrant further studies.
AIM: To investigate the prevalence and genotype distribution of Torque teno virus (TTV) in patients with different liver diseases and chronic renal failure treated at a referral hospital in North India. METHODS: Whereas prevalence of TTV was based on amplification of conserved region of ORF2 of TTV genome, the genotyping of TTV was carried out using restriction fragment length polymorphism (RFLP) procedure on the N22 region of ORF1. RESULTS:TTV-DNA was detected in 137 of 513 (26.7%) patients with liver diseases and 38 of 65 (58.5%) patients with chronic renal failure. TTV was also detected in 27% of healthy controls. The sequence analysis of the PCR product from 10 randomly selected cases failed to show a significant sequence divergence when compared with that of the TRM1 isolate of TTV genotype 1. The results of genotyping in 55 randomly selected patients showed the presence of genotype 1 (G1) in 53 (96.4%) and genotype 2 (G2) in 2 cases (3.6%), respectively. Other genotypes were not identified in this patient subgroup, suggesting that G1 is predominant in this area. The results of genotyping by RFLP were also supported by phylogenetic tree analysis, where G1 was found to be the major genotype. CONCLUSION: These results indicate that TTV is moderately present in Indian patients, with G1 to be the major genotype in North India. The pathogenicity and etiological role of TTV in different diseases is still a question mark and warrant further studies.
Authors: F Maggi; M Pistello; M Vatteroni; S Presciuttini; S Marchi; P Isola; C Fornai; S Fagnani; E Andreoli; G Antonelli; M Bendinelli Journal: J Virol Date: 2001-12 Impact factor: 5.103
Authors: L A Kondili; G Pisani; F Beneduce; G Morace; G Gentili; G Ballati; M Rapicetta Journal: J Pediatr Gastroenterol Nutr Date: 2001-11 Impact factor: 2.839
Authors: W L Irving; J K Ball; S Berridge; R Curran; A M Grabowska; C L Jameson; K R Neal; S D Ryder; B J Thomson Journal: J Infect Dis Date: 1999-07 Impact factor: 5.226
Authors: S Erensoy; A A Sayiner; S Türkoğlu; D Canatan; U S Akarca; R Sertöz; T Ozacar; Y Batur; S Badur; A Bilgiç Journal: Infection Date: 2002-10 Impact factor: 3.553
Authors: M Pistello; A Morrica; F Maggi; M L Vatteroni; G Freer; C Fornai; F Casula; S Marchi; P Ciccorossi; P Rovero; M Bendinelli Journal: J Med Virol Date: 2001-02 Impact factor: 2.327